2132 studies found for:    ovarian cancer
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Sarcoma;   Uterine Leiomyomata;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: laboratory biomarker analysis;   Other: screening questionnaire administration;   Procedure: study of high risk factors
2 Active, not recruiting Elizabeth Registry for Low Grade Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
3 Recruiting Chk1/2 Inhibitor (LY2606368) in Women With BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Non-High Risk Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer at Low Genetic Risk
Conditions: Ovarian Cancer;   Breast Cancer
Intervention: Drug: LY2606368
4 Recruiting Hypodontia and Ovarian Cancer
Conditions: Ovarian Cancer;   Hypodontia;   Breast Cancer;   Colon Cancer
Intervention:
5 Active, not recruiting M. D. Anderson Symptom Inventory - Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Behavioral: Interview;   Behavioral: Survey
6 Recruiting A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
Condition: Platinum Sensitive Ovarian Cancer
Interventions: Drug: Active comparator: Niraparib;   Drug: placebo
7 Recruiting Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
Condition: Ovarian Cancer
Intervention:
8 Recruiting Prophylactic Salpingectomy With Delayed Oophorectomy
Condition: Ovarian Carcinoma
Interventions: Other: Ovarian Cancer Screening;   Procedure: Prophylactic Salpingectomy with Delayed Oophorectomy;   Procedure: Risk-Reducing Salpingo-Oophorectomy;   Behavioral: Questionnaire;   Procedure: Transvaginal Ultrasound;   Behavioral: Phone Call
9 Recruiting AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Conditions: Breast Cancer;   Ovarian Cancer
Intervention: Drug: AZ2281 + Carboplatin
10 Completed Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Imatinib Mesylate;   Drug: Docetaxel
11 Recruiting Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Behavioral: Questionnaire;   Behavioral: Interview
12 Recruiting Interactive Educational Website for Women With Ovarian Cancer & Caregivers
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Recurrent Ovarian Cancer;   Fallopian Tube Cancer
Interventions: Behavioral: Usual Care Educational Website;   Behavioral: Prototype System
13 Unknown  A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Paclitaxel, Carboplatin and Vorinostat
14 Active, not recruiting Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
Condition: Ovarian Cancer
Intervention: Behavioral: Fertility-Sparing Survey
15 Completed
Has Results
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Bendamustine HCL
16 Recruiting Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status
Condition: Ovarian Cancer
Interventions: Drug: Veliparib;   Drug: Topotecan
17 Completed Women Surviving Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Quality of Life;   Survivorship
Intervention: Behavioral: questionnaires
18 Not yet recruiting Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: PET/CT(3hours]
19 Terminated Weekly Topotecan Therapy in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Topotecan
20 Withdrawn Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Carboplatin and / or taxol chemotherapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years